77 /100
CRITICAL RISK
Score updated May 29, 2026

SLXN — Silexion Therapeutics Corp Dilution Risk Tracker

Track SLXN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SLXN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
40
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
43%
📜 Warrant Exercise 60%
• Massive warrant overhang: 739540% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
📉 Score Deterioration 15%
• Score already CRITICAL (77/100) — events likely imminent
🔔 Track SLXN — Get forecast alerts →

💹 Market Data

Market Cap$179.2K
Shares Outstanding419.0K
FloatN/A
Cash$2.41M
Debt$1.99M
Short InterestN/A

🏛 Institutional Holdings

4.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SLXN for full holder detail →

📉 Short Interest

Short Interest33.1K
Days to Cover1.0
% of Float0.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Feb 25, 2026
4 INSIDER TRANSACTION Feb 23, 2026
4 INSIDER TRANSACTION Feb 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SLXN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SLXN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SLXN
📊 SLXN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SLXN Signal Convergence & Dark Pool Activity — StonkWhisper 📄 SLXN Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.